Potentia Wealth Invests $141,000 in Oscar Health, Inc. (NYSE:OSCR)

Potentia Wealth bought a new stake in Oscar Health, Inc. (NYSE:OSCR) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 10,509 shares of the company’s stock, valued at approximately $141,000.

A number of other large investors have also recently bought and sold shares of the stock. State Street Corp lifted its position in shares of Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after acquiring an additional 291,335 shares in the last quarter. Lingotto Investment Management LLP purchased a new position in Oscar Health in the 4th quarter valued at about $2,543,000. GDS Wealth Management boosted its stake in shares of Oscar Health by 1,545.3% during the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company’s stock worth $4,648,000 after purchasing an additional 324,798 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of Oscar Health by 296.0% during the 4th quarter. Victory Capital Management Inc. now owns 231,059 shares of the company’s stock worth $3,105,000 after purchasing an additional 172,706 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Oscar Health during the fourth quarter worth about $5,672,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Trading Up 7.3 %

OSCR stock opened at $14.00 on Tuesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.51 billion, a price-to-earnings ratio of -699.40 and a beta of 1.75. The business has a fifty day simple moving average of $15.03 and a 200-day simple moving average of $16.18. Oscar Health, Inc. has a 52 week low of $12.43 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analyst Upgrades and Downgrades

OSCR has been the subject of several recent analyst reports. Wells Fargo & Company cut shares of Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Jefferies Financial Group started coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Oscar Health has a consensus rating of “Hold” and an average target price of $20.21.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.